A study to find out the effectiveness of measles, mumps, rubella(mmr) vaccine in the treatment of common warts and to compare its efficacy with formic acid treatment of common warts.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- THOSE SUFFERING FROM COMMON WARTS
- Registration Number
- CTRI/2017/07/009041
- Lead Sponsor
- Myfanwy Joanne Dsouza
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Age above 18 years.
Patients satisfying the diagnostic criteria.
Common warts restricted only to the hands and feet, upto a maximum of 10 lesions.
Patients willing for the intervention with a written informed consent.
Exclusion Criteria
Age more than 72 years.
Patients with secondary infection of the warts.
Pregnant and lactating women.
Immunocompromised individuals.
Individuals with chronic and systemic illnesses like Diabetes mellitus, renal diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method